The promised land of human immunology

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 78, Issue 1, 2013, Pages 203-213

  Su, Laura F ^a   Han, Arnold ^b   Mcguire, Helen M ^b   Furman, David ^b   Newel, Evan W ^c   Davis, Mark M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHABETA T CELL RECEPTOR; COMPLEMENT; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACCINE; INFLUENZA VACCINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CELIAC DISEASE; CROSS REACTION; DATA ANALYSIS; HUMAN; IMMUNITY; IMMUNOLOGY; INBRED MOUSE STRAIN; MEMORY T LYMPHOCYTE; MOUSE MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYSTEMS BIOLOGY; T LYMPHOCYTE; ANIMAL; CYTOLOGY; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TECHNIQUE; INFLUENZA; MALE; METABOLISM; MOUSE; RISK;

ANIMALS; CELIAC DISEASE; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOLOGIC TECHNIQUES; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MICE; ODDS RATIO; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SYSTEMS BIOLOGY; T-LYMPHOCYTES;

EID: 84904917314     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2013.78.022905     Document Type: Article

References (63)

1. Aaby P, Martins CL, Garly ML, Bale C, Andersen A, Rodrigues A, Ravn H, Lisse IM, Benn CS, Whittle HC. 2010. Nonspecific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: Randomised controlled trial. BMJ 341: c6495.
2. Akue AD, Lee JY, Jameson SC. 2012. Derivation and maintenance of virtual memory CD8 T cells. J Immunol 188: 2516-2523.
3. Amur S, Parekh A, Mummaneni P. 2012. Sex differences and genomics in autoimmune diseases. J Autoimmun 38: J254-J265.
4. Bandura DR, Baranov VI, Ornatsky OI, Antonov A, Kinach R, Lou X, Pavlov S, Vorobiev S, Dick JE, Tanner SD. 2009. Mass cytometry: Technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 81: 6813-6822.
5. Bendall SC, Simonds EF, Qiu P, Amir el-AD, Krutzik PO, Finck R, Bruggner RV, Melamed R, Trejo A, Ornatsky OI, et al. 2011. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332: 687-696.
6. Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, Selin LK. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat Immunol 3: 627-634.
7. Casanova JL, Abel L. 2005. Inborn errors of immunity to infection:The rule rather than the exception. J Exp Med 202: 197-201.
8. Chu HH, Moon JJ, Kruse AC, Pepper M, Jenkins MK. 2010. Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations. J Immunol 185: 4705-4713.
9. Coppieters KT, Dotta F, Amirian N, Campbell PD, Kay TW, Atkinson MA, Roep BO, von Herrath MG. 2012. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209: 51-60.
10. Davis MM. 2008. A prescription for human immunology. Immunity 29: 835-838.
11. Decman V, Laidlaw BJ, Doering TA, Leng J, Ertl HC, Goldstein DR, Wherry EJ. 2012. Defective CD8 T cell responses in aged mice are due to quantitative and qualitative changes in virus-specific precursors. J Immunol 188: 1933-1941.
12. {thorn} T cells. J Immunol 182: 7440-7450.
13. Du Pre MF, Kozijn AE, van Berkel LA, ter Borg MN, Lindenbergh-Kortleve D, Jensen LT, Kooy-Winkelaar Y, Koning F, Boon L, Nieuwenhuis EE, et al. 2011. Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology 141: 610-620, 620 e611-e612.
14. Fallang LE, Bergseng E, Hotta K, Berg-Larsen A, Kim CY, Sollid LM. 2009. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol 10:1096-1101.
15. Feldmann M, Maini RN. 2001. Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 19: 163-196.
16. Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, Tse T, Huang H, Lund P, Maecker HT, et al. 2013a. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 9: 659.
17. Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. 2013b. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci 111: 869-874.
18. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, Moser JM, Mehta RS, Drake DR III, Castro E, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205: 3119-3131.
19. Green PH, Cellier C. 2007. Celiac disease. New Engl J Med 357: 1731-1743.
20. Grosso JF, Jure-Kunkel MN. 2013. CTLA-4 blockade in tumor models: An overview of preclinical and translational research. Cancer Immun 13: 5.
21. {thorn} T cell responses. Cancer Immunol Immunother 59: 1425-1433.
22. Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, Castermans E, Thor Straten P, Blank C, Haanen JB, et al. 2009. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods 6: 520-526.
23. {thorn} T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med 206: 435-448.
24. {thorn} alphabeta T cells and gammadelta T cells in celiac disease. Proc Natl Acad Sci 110: 13073-13078.
25. Harvey CJ, Wucherpfennig KW. 2013. Cracking the code of human T-cell immunity. Nat Biotechnol 31: 609-610.
26. Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, et al. 2013. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 5: 145-208.
27. Jabri B, Sollid LM. 2009. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 9:858-870.
28. {thorn} T lymphocytes. Nature 421: 852-856.
29. Klein SL, Poland GA. 2013. Personalized vaccinology: One size and dose might not fit both sexes. Vaccine 31: 2599-2600.
30. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP IV, Petersen LR. 1995. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. New Engl J Med 333: 1721-1725.
31. LamkanfiM, Dixit VM. 2012. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28: 137-161.
32. Laubach VE, Foley PL, Shockey KS, Tribble CG, Kron IL. 1998. Protective roles of nitric oxide and testosterone in endotoxemia:Evidence from NOS-2-deficient mice. Am J Physiol 275: H2211-H2218.
33. Meresse B, Malamut G, Cerf-Bensussan N. 2012. Celiac disease:An immunological jigsaw. Immunity 36: 907-919.
34. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK. 2007. Naive CD4({thorn}) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
35. Nakanishi Y, Lu B, Gerard C, Iwasaki A. 2009. CD8({thorn}) T lymphocyte mobilization to virus-infected tissue requires CD4({thorn}) T-cell help. Nature 462: 510-513.
36. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, et al. 2011. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12: 786-795.
37. Newell EW, Davis MM. 2014. Beyond model antigens: Highly dimensional analysis of antigen-specific T cells. Nat Biotechnol doi: 10.1038/nbt.2783. [Epub ahead of print].
38. Newell EW, Klein LO, Yu W, Davis MM. 2009. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat Methods 6: 497-499.
39. Newell EW, Ely LK, Kruse AC, Reay PA, Rodriguez SN, Lin AE, Kuhns MS, Garcia KC, Davis MM. 2011. Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k). J Immunol 186: 5823-5832.
40. {thorn} T cell phenotypes. Immunity 36: 142-152.
41. Newell EW, Sigal N, Nair N, Kidd BA, Greenberg HB, Davis MM. 2013. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat Biotechnol 31: 623-629.
42. Pentcheva-Hoang T, Corse E, Allison JP. 2009. Negative regulators of T-cell activation: Potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol Rev 229: 67-87.
43. Price JV, Jarrell JA, Furman D, Kattah NH, Newell E, Dekker CL, Davis MM, Utz PJ. 2013. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One 8: e64555.
44. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203:413-424.
45. Raki M, Fallang LE, Brottveit M, Bergseng E, Quarsten H, Lundin KE, Sollid LM. 2007. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci 104: 2831-2836.
46. Reinherz EL, Tan K, Tang L, Kern P, Liu J, Xiong Y, Hussey RE, Smolyar A, Hare B, Zhang R, et al. 1999. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286: 1913-1921.
47. Reiser JB, Darnault C, Gregoire C, Mosser T, Mazza G, Kearney A, van der Merwe PA, Fontecilla-Camps JC, Housset D, Malissen B. 2003. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat Immunol 4: 241-247.
48. Rudd BD, Venturi V, Li G, Samadder P, Ertelt JM, Way SS, Davenport MP, Nikolich-Zugich J. 2011. Nonrandom attrition of the naive CD8+ T-cell pool with aging governed by T-cell receptor:pMHC interactions. Proc Natl Acad Sci 108:13694-13699.
49. Sandberg-Bennich S, Dahlquist G, Kallen B. 2002. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr 91: 30-33.
50. Selin LK, Nahill SR, Welsh RM. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 179: 1933-1943.
51. Seok J,Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci 110:3507-3512.
52. Shedlock DJ, Shen H. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-339.
53. Sollid LM, Jabri B. 2013. Triggers and drivers of autoimmunity:Lessons from coeliac disease. Nat Rev Immunol 13: 294-302.
54. Sollid LM, Qiao SW, Anderson RP, Gianfrani C, Koning F. 2012. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 64: 455-460.
55. Sorup S, Villumsen M, Ravn H, Benn CS, Sorensen TI, Aaby P, Jess T, Roth A. 2011. Smallpox vaccination and all-cause infectious disease hospitalization: A Danish register-based cohort study. Int J Epidemiol 40: 955-963.
56. Su LF, Kidd BA, Han A, Kotzin JJ, Davis MM. 2013. Virusspecific CD4({thorn}) memory-phenotype T cells are abundant in unexposed adults. Immunity 38: 373-383.
57. Sun JC, Bevan MJ. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-342.
58. Trowsdale J. 2011. The MHC, disease and selection. Immunol Lett 137: 1-8.
59. {thorn} T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 26: 1762-1769.
60. Weber S, Tian H, van Rooijen N, Pirofski LA. 2012. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcgamma receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice. Infect Immun 80: 1314-1322.
61. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183: 67-76.
62. Xian L, Wu X, Pang L, Lou M, Rosen CJ, Qiu T, Crane J, Frassica F, Zhang L, Rodriguez JP, et al. 2012. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18: 1095-1101.
63. Yang HY, Dundon PL, Nahill SR, Welsh RM. 1989. Virusinduced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 142: 1710-1718.